|
|
Am. J. Biomed. Sci. 2013, 5(1), 69-79; doi: 10.5099/aj130100069 |
Peroxynitrite-modified H3 Histone is Highly Immunogenic and Binds
Circulating SLE Autoantibodies Better than Native DNA |
M. Asad Khan1, Kiran
Dixit1, Zarina Arif2,
Moinuddin1, Jalaluddin M. Ashraf1
and |
Khursheed Alam1, * |
1Department of Biochemistry, Faculty of Medicine, |
2Rajiv Gandhi Centre for Diabetes and Endocrinology,
Faculty of Medicine, |
*Corresponding
author: |
Professor Khursheed Alam, Ph.D. |
Department of Biochemistry |
Faculty of Medicine |
|
|
Fax: +91-571-2720030 |
Email: kalam786@rediffmail.com |
Abstract Peroxynitrite
is a bifaceted reactive species. It can oxidize and
nitrate proteins/nucleic acids/lipids and is involved in inflammation,
apoptosis, cytotoxicity and autoimmune disorders of
unknown etiology, including SLE. In this study, H3 histone
exposed to peroxynitrite caused loss of tertiary
structure, nitration of tyrosine residues and dityrosine
formation. Experimentally produced antibodies against peroxynitrite-modified
H3 histone showed specificity for the immunogen. However, cross-reactions with other nitrated
proteins were also observed. We further investigated the binding of SLE autoantibodies with native DNA, native H3 histone and peroxynitrite-modified
H3 histone to explore the possible role of
modified-H3 histone in the initiation and/or
progression of SLE in a sub-group of patients. The results showed preferential
binding of SLE anti-nDNA autoantibodies
to peroxynitrite-modified H3 histone.
The visual detection of immune complex formation with native and peroxynitrite-modified H3 histone
reiterated preferential binding of SLE autoantibodies
with modified H3 histone. It may be concluded that
anti-histone autoantibodies
seen in a sub-group of SLE patients might be due to the immunogenicity of peroxynitrite-modified H3 histone. Keywords:
Peroxynitrite, nitrotyrosine,
SLE, H3 histone. Download the full article (PDF)
|
Publisher | Missions and Scope | Editorial Board | Instructions for Authors |
© American Journal of Biomedical Sciences 2007-2021. All Rights Reserved. |